Leonid Timashev
Stock Analyst at RBC Capital
(0)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VSTM Verastem | Maintains: Outperform | 16 12 | 4.16 | 188.46% | 1 | Jun 25, 2025 | |
CRMD Cormedix | Reiterates: Outperform | 13 17 | 14.99 | 13.41% | 1 | Jun 20, 2025 | |
ADCT ADC Therapeutics | Maintains: Outperform | 8 5 | 2.69 | 85.87% | 1 | Jun 20, 2025 | |
NUVB Nuvation Bio | Maintains: Outperform | 10 6 | 1.97 | 204.57% | 1 | Jun 17, 2025 | |
AXSM Axsome Therapeutics | Maintains: Outperform | 193 186 | 102.69 | 81.13% | 11 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 99 106 | 101.73 | 4.2% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 48 48 | 13.07 | 267.25% | 12 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 16 | 3.62 | 341.99% | 1 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | 54 21 | 14.75 | 42.37% | 12 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 82 80 | 33.92 | 135.85% | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Perform | 39 40 | 28.82 | 38.79% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 8 8 | 1.18 | 577.97% | 6 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 3 3 | 1.23 | 143.9% | 1 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 40 | 18.44 | 116.92% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 70 70 | 70.81 | -1.14% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 18 18 | 2.67 | 574.16% | 4 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 86 86 | 33.52 | 156.56% | 12 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 4 4 | 3.83 | 4.44% | 8 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | 240 20 | n/a | n/a | 1 | Oct 18, 2022 |